Woodmont Investment Counsel Decreased Abbvie (ABBV) Holding By $568,008; 4 Analysts Covering BRF S.A. (BRFS)

December 8, 2017 - By Winifred Garcia

Among 6 analysts covering BRF S.A. (NYSE:BRFS), 4 have Buy rating, 1 Sell and 1 Hold. Therefore 67% are positive. BRF S.A. had 11 analyst reports since September 16, 2015 according to SRatingsIntel. As per Wednesday, September 16, the company rating was downgraded by JP Morgan. JP Morgan upgraded it to “Overweight” rating and $14 target in Tuesday, May 31 report. Bank of America maintained BRF S.A. (NYSE:BRFS) on Friday, May 26 with “Buy” rating. The stock of BRF S.A. (NYSE:BRFS) earned “Sell” rating by Goldman Sachs on Monday, October 5. The rating was upgraded by Deutsche Bank on Friday, January 29 to “Buy”. The stock has “Neutral” rating by JP Morgan on Monday, January 9. Bank of America downgraded the stock to “Neutral” rating in Friday, October 30 report. JP Morgan upgraded BRF S.A. (NYSE:BRFS) on Thursday, September 14 to “Overweight” rating. The rating was upgraded by Citigroup on Thursday, October 8 to “Buy”. See BRF S.A. (NYSE:BRFS) latest ratings:

14/09/2017 Broker: JP Morgan Old Rating: Neutral New Rating: Overweight Upgrade

Woodmont Investment Counsel Llc decreased Abbvie Inc (ABBV) stake by 19.6% reported in 2017Q2 SEC filing. Woodmont Investment Counsel Llc sold 7,889 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Woodmont Investment Counsel Llc holds 32,354 shares with $2.35M value, down from 40,243 last quarter. Abbvie Inc now has $150.45 billion valuation. The stock decreased 0.17% or $0.16 during the last trading session, reaching $94.24. About 4.52 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since December 8, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.

BRF S.A. focuses on raising, producing, and slaughtering poultry and pork in Brazil, Latin America, Europe, the Middle East, Africa, and Asia. The company has market cap of $9.24 billion. The firm also processes, produces and sells fresh meat, processed foods, pasta, sauce, mayonnaise, frozen vegetables and soybean by-products. It currently has negative earnings. The Company’s product portfolio comprise whole chickens and frozen cuts of chicken, turkey, and pork; ham products, bologna, sausages, frankfurters, and other smoked products; hamburgers, breaded meat products, and meatballs; lasagnas, pizzas, cheese breads, pies, and frozen vegetables; margarine, sauces and mayonnaise; and soy meal and refined soy flour, and animal feed.

The stock decreased 4.72% or $0.54 during the last trading session, reaching $10.9. About 5.49 million shares traded or 207.48% up from the average. BRF S.A. (NYSE:BRFS) has declined 2.88% since December 8, 2016 and is downtrending. It has underperformed by 19.58% the S&P500.

Since June 14, 2017, it had 0 insider purchases, and 2 sales for $8.79 million activity. 79,800 shares were sold by Schumacher Laura J, worth $5.59M. $3.21M worth of AbbVie Inc. (NYSE:ABBV) shares were sold by ALBAN CARLOS.

Woodmont Investment Counsel Llc increased Vanguard Intl Equity Index F (VNQI) stake by 5,769 shares to 10,884 valued at $612,000 in 2017Q2. It also upped Ishares Tr (SHY) stake by 35,543 shares and now owns 41,118 shares. Ishares Inc (IEMG) was raised too.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 69 analyst reports since July 21, 2015 according to SRatingsIntel. Barclays Capital maintained it with “Equal-Weight” rating and $9 target in Friday, October 13 report. The stock of AbbVie Inc. (NYSE:ABBV) has “Hold” rating given on Wednesday, June 7 by BMO Capital Markets. Citigroup upgraded it to “Buy” rating and $65 target in Tuesday, February 23 report. The company was maintained on Thursday, May 25 by Jefferies. The stock of AbbVie Inc. (NYSE:ABBV) earned “Sell” rating by Societe Generale on Wednesday, April 6. The stock of AbbVie Inc. (NYSE:ABBV) has “Market Perform” rating given on Friday, June 10 by BMO Capital Markets. Raymond James initiated AbbVie Inc. (NYSE:ABBV) on Friday, September 2 with “Outperform” rating. The rating was maintained by UBS with “Neutral” on Friday, October 13. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by UBS on Friday, October 23. As per Friday, February 5, the company rating was initiated by William Blair.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 earnings per share, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28B for 16.48 P/E if the $1.43 EPS becomes a reality. After $1.41 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.

Investors sentiment increased to 1 in Q2 2017. Its up 0.01, from 0.99 in 2017Q1. It increased, as 55 investors sold ABBV shares while 581 reduced holdings. 138 funds opened positions while 500 raised stakes. 1.04 billion shares or 0.53% more from 1.04 billion shares in 2017Q1 were reported. Wills Fincl Inc owns 6,283 shares for 0.34% of their portfolio. Salem Management invested in 0.5% or 12,300 shares. Nippon Life stated it has 0.43% of its portfolio in AbbVie Inc. (NYSE:ABBV). Brinker Capital stated it has 54,745 shares. 44,745 are owned by Main Street Research Ltd. Gradient Investments Ltd Co owns 103,577 shares. Amalgamated Comml Bank, New York-based fund reported 187,983 shares. Cibc invested in 0.17% or 224,899 shares. Hilltop reported 32,866 shares or 0.7% of all its holdings. Forte Cap Limited Liability Company Adv, New York-based fund reported 15,511 shares. Cincinnati Fincl accumulated 1.17% or 341,800 shares. Cincinnati holds 1.38 million shares or 3.1% of its portfolio. Loomis Sayles And Communication Limited Partnership owns 0% invested in AbbVie Inc. (NYSE:ABBV) for 22,683 shares. The Illinois-based New England And has invested 0.25% in AbbVie Inc. (NYSE:ABBV). Altavista Wealth Management reported 0.16% stake.